Clinical Application of 18F-PFPN PET Imaging in Diagnosis and Staging of Clear Cell Sarcoma of Soft Tissue
Clear Cell Sarcoma of Soft Tissue
About this trial
This is an interventional diagnostic trial for Clear Cell Sarcoma of Soft Tissue
Eligibility Criteria
Inclusion Criteria: Adult patients (age 18 years or above), regardless of gender; Patients with clinically suspected or confirmed clear cell sarcoma of soft tissue (supporting evidence including visual examination, MRI, CT, ultrasound, and histopathological examination, etc.) ; Patients who agree to undergo both 18F-PFPN and 18F-FDG PET imaging. Exclusion Criteria: Acute systemic diseases and electrolyte disturbances; Patients who plan to get pregnant within six months or are pregnant or breastfeeding; The patient or his/her legal representative is unable or unwilling to sign the informed consent.
Sites / Locations
- China, Hubei ProvinceRecruiting
Arms of the Study
Arm 1
Experimental
18F-PFPN PET
A positron probe for the targeted melanin